References
- Li L, Leid M, Rothenberg EV. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science. 2010;329:89–93.
- Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Takeda N, et al. Bcl11b is required for differentiation and survival of αβ T lymphocytes. Nat Immunol. 2003;4:533–9.
- Cismasiu VB, Ghanta S, Duque J, Albu D, Chen HM, Kasturi R. BCL11B participates in the activation of interleukin-2 gene expression in CD4+ T lymphocytes. Blood. 2006;108:2695–702.
- Avram D, Fields A, Senawong T, Topark-Ngarm A, Leid M. COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. Biochem J. 2002;368:555–63.
- Tanaka M, Zheng J, Kitajima K, Kita K, Yoshikawa H, Nakano T. Differentiation status dependent function of FOG-1. Genes Cells. 2004;9:1213–26.
- Garcon L, Lacout C, Svinartchouk F, Couedic JPL, Villeval JL, Vainchenker W, et al. Gfi-1B plays a criticla role in terminal differentiation of normal and transformed erythroid pro-genitor cells. Blood. 2005;105:1448–55.
- Yang HY, Kim SH, Kim SH, Kim DJ, Kim SU, Yu DY, et al. The suppression of zfpm-1 accelerates the erythropoietic differentiation of human CD34+ cells. Biochem Biophys Res Commun. 2007;353:978–84.
- Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero JI, et al. Disruption of the BCL11B gene through inv 14 q11.2q32.31 results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia. 2005;19:201–8.
- Huang X, Chen S, Shen Q, Yang LJ, Li B, Zhong LY, et al. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. J Hematol Oncol. 2010;3:44.
- Nagel S, Kaufmann M, Drexler HG, MacLeod RA. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res. 2003;63:5329–34.
- Oshiro A, Tagawa H, Ohshima K, Karube K, Uike N, Tashiro Y, et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood. 2006;107:4500–7.
- Huang X, Chen S, Shen Q, Chen SH, Yang LJ, Grabarczyk P, et al. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNAsiRNA935. Hematology. 2011;16:236–42.
- Chen S, Huang X, Chen SH, Yang LJ, Shen Q, Zheng HT, et al. The role of BCL11B in regulating the proliferation of human naïve T cells. Hum Immunol. 2012;73:456–64.
- Grabarczyk P, Przybylski GK, Depke M. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene. 2007;26:3797–810.
- Durum SK. BCL11: sibling rivalry in lymphoid development. Nat Immunol. 2003;4:512–4.
- Huang X, Shen Q, Chen S, Chen SH, Yang LJ, Weng JY, et al. Gene expression profiles in BCL11B-siRNA treated malignant T cells. J Hematol Oncol. 2011;4:23.
- Wiehe JM, Ponsaerts P, Rojewski MT, Homann JM, Greiner J, Kronawitter D, et al. mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression. J Cell Mol Med. 2007;11:521–30.
- Choo A, Palladinetti P, Holmes T, Basu S, Shen S, Lock RB, et al. siRNA targeting the IRF2 transcription factor inhibits leukaemic cell growth. Int J Oncol. 2008;33:175–83.
- Kim I, Kim YJ, Métais JY, Dunbar CE, Larochelle A. Transient silencing of PTEN in human CD34+ cells enhances their proliferative potential and ability to engraft immunodeficient mice. Exp Hematol. 2012;40:84–91.